Finding a possible biomarker to tackle Parkinson’s disease by splice analysis and random point mutations to counter the expression of genes involved in Parkinson’s disease

Piyusha Kalwad, Ranjitha Guttapadu, Pradeep S


The genes showing aberrant alternative splicing in Parkinson’s disease namely SNCA, SNCAIP, LRRK2, SRRM2, MAPT and PARK2 were analysed. Two of the genes, namely SNCAIP and SRRM2 that showed high effect were taken and splice site analysis was carried out. Random mutations were carried out on these two genes using Human Splicing Finder tool and the mutations showing the most promising results (i.e., mutations that can restore natural gene expression) were appropriately chosen to tackle Parkinson’s disease.

Int. J. Appl. Sci. Biotechnol. Vol 5(3): 336-344


Parkinson’s disease; phylogenetic analysis; splice site analysis; mutations, Human Splicing Finder; biomarker discovery

Full Text:



Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


  • There are currently no refbacks.

Copyright (c) 2017 International Journal of Applied Sciences and Biotechnology

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.